1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Hinds, M.G.
Zhang, W.
Anderluh, G.
Hansen, P.E.
Norton, R.S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
315
1219
1229
10.1006/jmbi.2001.5321
11827489
Solution structure of the eukaryotic pore-forming cytolysin equinatoxin II: implications for pore formation.
2002
NE
J.Biomol.NMR
JBNME9
0800
0925-2738
18
281
282
10.1023/A:1026793926271
Sequence-specific resonance assignments of the potent cytolysin equinatoxin II
2000
10.2210/pdb1kd6/pdb
pdb_00001kd6
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
19859.453
EQUINATOXIN II
1
man
polymer
EqtII, Tenebrosin C
no
no
SADVAGAVIDGASLSFDILKTVLEALGNVKRKIAVGVDNESGKTWTALNTYFRSGTSDIVLPHKVPHGKALLYNGQKDRG
PVATGAVGVLAYLMSDGNTLAVLFSVPYDYNWYSNWWNVRIYKGKRRADQRMYEELYYNLSPFRGDNGWHTRNLGYGLKS
RGFMNSSGHAILEIHVTKA
SADVAGAVIDGASLSFDILKTVLEALGNVKRKIAVGVDNESGKTWTALNTYFRSGTSDIVLPHKVPHGKALLYNGQKDRG
PVATGAVGVLAYLMSDGNTLAVLFSVPYDYNWYSNWWNVRIYKGKRRADQRMYEELYYNLSPFRGDNGWHTRNLGYGLKS
RGFMNSSGHAILEIHVTKA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Actinia
Escherichia
Escherichia coli
sample
6106
Actinia equina
469008
Escherichia coli BL21(DE3)
BL21(DE3)
PLASMID
pAG2.1
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-02-13
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
SEQUENCE
THERE ARE TWO NATURALLY OCCURING SEQUENCE VARIANTS P116D AND T212S
FOR EQUINATOXIN II
P116D VARIANT OCCURS IN 50% OF MOLECULES FROM ACTINIA EQUINA
AND THE T212S VARIANT IN ACTINA TENEBROSA.
RCSB
Y
RCSB
2001-11-12
REL
The structure was determined using triple resonance spectroscopy
structures with acceptable covalent geometry,structures with the least restraint violations
250
20
3D_13C-separated_NOESY
3D_15N-separated_NOESY
HNHA
NOESY
3.9
ambient
303
K
The structure is based on 3161 total restraints including 167 angle constraints, 42 hydrogen bonds, 534 sequential, 972 short range and 1346 long range distance constraints.
torsion angle dyanamics
distance geometry
simulated annealing
1
closest to the average
1mM 13C, 15N Equinatoxin II pH 3.9
90% H2O, 10% H2O
1mM 15N Equinatoxin II pH 3.9
90% H2O, 10% H2O
1mM unlabelled Equinatoxin II pH 3.9
90% H2O, 10% H2O
Varian Associates
collection
VNMR
6
Bruker AG
processing
XwinNMR
2.6
Bartels, C., Xia, T.H., Guntert, P., Wuthrich K. J Biomol NMR. 1995, 6, 1-10.
data analysis
XEASY
1.3.13
Guntert, P., Mumenthaler, C., Wuthrich, K.J. Mol. Biol. 1997, 273, 283-298.
structure solution
DYANA
1.5
Brunger, A.T., Adams, P.D., Clore, G.M., Delano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S, Read, R.J., Rice, L.M., Simonson, T., Warren, G.L. Acta Crystallogr. D Biol. Crystallogr. 1998, 54, 905-921.
refinement
CNS
1.0
600
Varian
INOVA
750
Varian
INOVA
800
Varian
INOVA
600
Bruker
DRX
SER
1
n
1
SER
1
A
ALA
2
n
2
ALA
2
A
ASP
3
n
3
ASP
3
A
VAL
4
n
4
VAL
4
A
ALA
5
n
5
ALA
5
A
GLY
6
n
6
GLY
6
A
ALA
7
n
7
ALA
7
A
VAL
8
n
8
VAL
8
A
ILE
9
n
9
ILE
9
A
ASP
10
n
10
ASP
10
A
GLY
11
n
11
GLY
11
A
ALA
12
n
12
ALA
12
A
SER
13
n
13
SER
13
A
LEU
14
n
14
LEU
14
A
SER
15
n
15
SER
15
A
PHE
16
n
16
PHE
16
A
ASP
17
n
17
ASP
17
A
ILE
18
n
18
ILE
18
A
LEU
19
n
19
LEU
19
A
LYS
20
n
20
LYS
20
A
THR
21
n
21
THR
21
A
VAL
22
n
22
VAL
22
A
LEU
23
n
23
LEU
23
A
GLU
24
n
24
GLU
24
A
ALA
25
n
25
ALA
25
A
LEU
26
n
26
LEU
26
A
GLY
27
n
27
GLY
27
A
ASN
28
n
28
ASN
28
A
VAL
29
n
29
VAL
29
A
LYS
30
n
30
LYS
30
A
ARG
31
n
31
ARG
31
A
LYS
32
n
32
LYS
32
A
ILE
33
n
33
ILE
33
A
ALA
34
n
34
ALA
34
A
VAL
35
n
35
VAL
35
A
GLY
36
n
36
GLY
36
A
VAL
37
n
37
VAL
37
A
ASP
38
n
38
ASP
38
A
ASN
39
n
39
ASN
39
A
GLU
40
n
40
GLU
40
A
SER
41
n
41
SER
41
A
GLY
42
n
42
GLY
42
A
LYS
43
n
43
LYS
43
A
THR
44
n
44
THR
44
A
TRP
45
n
45
TRP
45
A
THR
46
n
46
THR
46
A
ALA
47
n
47
ALA
47
A
LEU
48
n
48
LEU
48
A
ASN
49
n
49
ASN
49
A
THR
50
n
50
THR
50
A
TYR
51
n
51
TYR
51
A
PHE
52
n
52
PHE
52
A
ARG
53
n
53
ARG
53
A
SER
54
n
54
SER
54
A
GLY
55
n
55
GLY
55
A
THR
56
n
56
THR
56
A
SER
57
n
57
SER
57
A
ASP
58
n
58
ASP
58
A
ILE
59
n
59
ILE
59
A
VAL
60
n
60
VAL
60
A
LEU
61
n
61
LEU
61
A
PRO
62
n
62
PRO
62
A
HIS
63
n
63
HIS
63
A
LYS
64
n
64
LYS
64
A
VAL
65
n
65
VAL
65
A
PRO
66
n
66
PRO
66
A
HIS
67
n
67
HIS
67
A
GLY
68
n
68
GLY
68
A
LYS
69
n
69
LYS
69
A
ALA
70
n
70
ALA
70
A
LEU
71
n
71
LEU
71
A
LEU
72
n
72
LEU
72
A
TYR
73
n
73
TYR
73
A
ASN
74
n
74
ASN
74
A
GLY
75
n
75
GLY
75
A
GLN
76
n
76
GLN
76
A
LYS
77
n
77
LYS
77
A
ASP
78
n
78
ASP
78
A
ARG
79
n
79
ARG
79
A
GLY
80
n
80
GLY
80
A
PRO
81
n
81
PRO
81
A
VAL
82
n
82
VAL
82
A
ALA
83
n
83
ALA
83
A
THR
84
n
84
THR
84
A
GLY
85
n
85
GLY
85
A
ALA
86
n
86
ALA
86
A
VAL
87
n
87
VAL
87
A
GLY
88
n
88
GLY
88
A
VAL
89
n
89
VAL
89
A
LEU
90
n
90
LEU
90
A
ALA
91
n
91
ALA
91
A
TYR
92
n
92
TYR
92
A
LEU
93
n
93
LEU
93
A
MET
94
n
94
MET
94
A
SER
95
n
95
SER
95
A
ASP
96
n
96
ASP
96
A
GLY
97
n
97
GLY
97
A
ASN
98
n
98
ASN
98
A
THR
99
n
99
THR
99
A
LEU
100
n
100
LEU
100
A
ALA
101
n
101
ALA
101
A
VAL
102
n
102
VAL
102
A
LEU
103
n
103
LEU
103
A
PHE
104
n
104
PHE
104
A
SER
105
n
105
SER
105
A
VAL
106
n
106
VAL
106
A
PRO
107
n
107
PRO
107
A
TYR
108
n
108
TYR
108
A
ASP
109
n
109
ASP
109
A
TYR
110
n
110
TYR
110
A
ASN
111
n
111
ASN
111
A
TRP
112
n
112
TRP
112
A
TYR
113
n
113
TYR
113
A
SER
114
n
114
SER
114
A
ASN
115
n
115
ASN
115
A
TRP
116
n
116
TRP
116
A
TRP
117
n
117
TRP
117
A
ASN
118
n
118
ASN
118
A
VAL
119
n
119
VAL
119
A
ARG
120
n
120
ARG
120
A
ILE
121
n
121
ILE
121
A
TYR
122
n
122
TYR
122
A
LYS
123
n
123
LYS
123
A
GLY
124
n
124
GLY
124
A
LYS
125
n
125
LYS
125
A
ARG
126
n
126
ARG
126
A
ARG
127
n
127
ARG
127
A
ALA
128
n
128
ALA
128
A
ASP
129
n
129
ASP
129
A
GLN
130
n
130
GLN
130
A
ARG
131
n
131
ARG
131
A
MET
132
n
132
MET
132
A
TYR
133
n
133
TYR
133
A
GLU
134
n
134
GLU
134
A
GLU
135
n
135
GLU
135
A
LEU
136
n
136
LEU
136
A
TYR
137
n
137
TYR
137
A
TYR
138
n
138
TYR
138
A
ASN
139
n
139
ASN
139
A
LEU
140
n
140
LEU
140
A
SER
141
n
141
SER
141
A
PRO
142
n
142
PRO
142
A
PHE
143
n
143
PHE
143
A
ARG
144
n
144
ARG
144
A
GLY
145
n
145
GLY
145
A
ASP
146
n
146
ASP
146
A
ASN
147
n
147
ASN
147
A
GLY
148
n
148
GLY
148
A
TRP
149
n
149
TRP
149
A
HIS
150
n
150
HIS
150
A
THR
151
n
151
THR
151
A
ARG
152
n
152
ARG
152
A
ASN
153
n
153
ASN
153
A
LEU
154
n
154
LEU
154
A
GLY
155
n
155
GLY
155
A
TYR
156
n
156
TYR
156
A
GLY
157
n
157
GLY
157
A
LEU
158
n
158
LEU
158
A
LYS
159
n
159
LYS
159
A
SER
160
n
160
SER
160
A
ARG
161
n
161
ARG
161
A
GLY
162
n
162
GLY
162
A
PHE
163
n
163
PHE
163
A
MET
164
n
164
MET
164
A
ASN
165
n
165
ASN
165
A
SER
166
n
166
SER
166
A
SER
167
n
167
SER
167
A
GLY
168
n
168
GLY
168
A
HIS
169
n
169
HIS
169
A
ALA
170
n
170
ALA
170
A
ILE
171
n
171
ILE
171
A
LEU
172
n
172
LEU
172
A
GLU
173
n
173
GLU
173
A
ILE
174
n
174
ILE
174
A
HIS
175
n
175
HIS
175
A
VAL
176
n
176
VAL
176
A
THR
177
n
177
THR
177
A
LYS
178
n
178
LYS
178
A
ALA
179
n
179
ALA
179
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
TYR
73
A
O
TYR
73
A
N
VAL
35
A
N
VAL
35
A
N
ALA
34
A
N
ALA
34
A
O
ALA
170
A
O
ALA
170
A
O
THR
177
A
O
THR
177
A
N
LYS
159
A
N
LYS
159
A
O
SER
160
A
O
SER
160
A
N
ARG
152
A
N
ARG
152
A
N
THR
46
A
N
THR
46
A
O
LEU
93
A
O
LEU
93
A
N
GLY
88
A
N
GLY
88
A
O
PHE
104
A
O
PHE
104
A
N
THR
99
A
N
THR
99
A
O
TYR
122
A
O
TYR
122
A
N
TRP
117
A
N
TRP
117
A
O
PHE
143
A
O
PHE
143
2
A
A
HG3
HA
LYS
ALA
159
179
1.26
2
A
A
HA
HG3
ALA
MET
128
132
1.27
2
A
A
HD12
HB3
LEU
HIS
23
169
1.30
2
A
A
HD23
HB3
LEU
ALA
14
70
1.32
2
A
A
OD1
H
ASP
GLN
129
130
1.56
3
A
A
HA
HB2
TRP
PHE
149
163
1.33
3
A
A
HZ1
O
LYS
ALA
159
179
1.59
4
A
A
HE2
HG
PHE
LEU
104
172
1.13
4
A
A
HE3
HA2
LYS
GLY
77
85
1.20
4
A
A
HZ1
HD1
LYS
TYR
77
108
1.24
4
A
A
HA
HB2
TRP
PHE
149
163
1.28
4
A
A
HG22
HE3
VAL
MET
89
132
1.31
4
A
A
O
H
SER
VAL
54
87
1.57
5
A
A
HG23
H
VAL
LYS
29
30
1.28
5
A
A
HD13
HZ2
LEU
LYS
26
32
1.28
6
A
A
HZ2
HD2
TRP
HIS
117
150
1.26
6
A
A
H
O
THR
TYR
99
122
1.59
8
A
A
O
H
TYR
TYR
108
110
1.59
9
A
A
HZ2
HE2
TRP
HIS
117
150
1.33
9
A
A
HZ2
OXT
LYS
ALA
159
179
1.56
10
A
A
HB3
HB3
ALA
LEU
47
61
1.27
11
A
A
HB2
H
PRO
HIS
66
67
1.34
13
A
A
HD1
H
PHE
MET
163
164
1.18
13
A
A
O
HG
TYR
SER
113
114
1.58
14
A
A
HZ2
HE2
TRP
HIS
117
150
1.27
14
A
A
HG21
HG
VAL
LEU
89
103
1.27
14
A
A
HZ2
OXT
LYS
ALA
159
179
1.59
15
A
A
HE3
HA
LYS
ALA
77
83
1.34
15
A
A
HD11
HD3
LEU
LYS
26
32
1.34
15
A
A
HZ2
OXT
LYS
ALA
159
179
1.59
16
A
A
HZ2
HE2
TRP
HIS
117
150
1.08
16
A
A
HZ3
HA2
LYS
GLY
77
85
1.31
16
A
A
OD1
H
ASP
GLN
129
130
1.60
17
A
A
HD13
HA
LEU
LYS
158
178
1.27
17
A
A
HD21
HG11
ASN
VAL
39
65
1.34
19
A
A
HZ2
HE2
TRP
HIS
117
150
1.19
19
A
A
HB2
H
PRO
HIS
66
67
1.31
19
A
A
HA3
HA
GLY
ILE
162
174
1.35
20
A
A
HG22
HG
VAL
LEU
89
103
1.29
1
A
ALA
2
-146.51
-56.61
1
A
ALA
5
-109.02
44.86
1
A
ALA
7
-97.04
44.87
1
A
ALA
12
-154.66
-32.95
1
A
ALA
25
-90.18
34.41
1
A
ASN
28
-78.44
43.66
1
A
SER
54
-133.98
-70.89
1
A
THR
56
-165.61
-167.46
1
A
SER
57
-159.96
-53.53
1
A
HIS
63
-119.48
51.29
1
A
GLN
76
-145.19
46.60
1
A
LYS
77
52.64
175.81
1
A
ARG
79
72.86
-46.93
1
A
PRO
81
-71.53
-142.10
1
A
SER
95
-167.35
-100.34
1
A
TYR
108
-84.26
40.12
1
A
ASN
111
-160.76
-131.61
1
A
ARG
126
69.99
129.32
1
A
ASP
129
-161.19
-159.42
1
A
GLU
135
56.80
-56.51
1
A
TYR
137
-78.34
40.46
1
A
SER
141
-153.38
76.94
1
A
ASN
147
-47.19
92.17
1
A
ARG
152
-171.50
144.16
1
A
PHE
163
-175.15
-174.58
1
A
SER
166
-82.36
-121.50
1
A
GLU
173
-116.40
75.85
2
A
ALA
5
70.00
131.72
2
A
ALA
12
-154.87
-38.75
2
A
LEU
26
-80.78
44.90
2
A
ASN
28
-135.09
-45.84
2
A
SER
41
-92.52
-76.93
2
A
LEU
48
-120.45
-57.73
2
A
THR
56
-171.06
143.18
2
A
ASP
58
-176.84
37.27
2
A
ILE
59
60.99
-65.92
2
A
LYS
77
-80.36
-155.20
2
A
ASP
78
68.05
119.15
2
A
ARG
79
-170.42
-40.84
2
A
ALA
83
-143.49
41.59
2
A
ALA
86
-165.83
105.06
2
A
MET
94
-81.81
-93.20
2
A
SER
95
-151.17
-45.74
2
A
ASP
96
-89.68
33.25
2
A
ASP
109
69.60
145.49
2
A
TYR
110
-84.23
42.03
2
A
ASN
111
-80.18
-114.60
2
A
TRP
112
-153.49
37.97
2
A
LYS
123
-82.18
46.84
2
A
ARG
126
72.39
123.14
2
A
ASP
129
-157.18
-153.93
2
A
ASN
139
-88.55
44.83
2
A
SER
141
-154.65
62.84
2
A
ASN
147
-51.50
97.37
2
A
SER
166
-85.07
-131.38
2
A
SER
167
62.59
-145.52
3
A
VAL
4
61.07
61.46
3
A
ALA
12
-162.54
-28.07
3
A
LEU
26
-80.23
48.40
3
A
SER
54
-110.34
-78.87
3
A
SER
57
-166.27
-58.85
3
A
HIS
63
-177.98
-50.83
3
A
PRO
66
-77.35
-119.27
3
A
ARG
79
72.53
145.54
3
A
ALA
86
-165.72
119.91
3
A
SER
95
-163.09
-101.94
3
A
TYR
108
-93.49
42.43
3
A
ASN
111
-132.12
-130.93
3
A
LYS
125
69.24
-46.22
3
A
TYR
133
-131.29
-41.76
3
A
GLU
135
-140.05
-58.65
3
A
TYR
138
-82.18
47.86
3
A
ASN
139
-147.84
-38.43
3
A
SER
141
-151.86
61.52
3
A
PHE
143
-73.25
-111.43
3
A
ARG
144
-170.33
-4.75
3
A
ASN
147
-53.25
88.93
3
A
SER
166
-98.63
-119.63
3
A
SER
167
70.83
-45.57
4
A
ASP
3
66.06
124.72
4
A
ALA
7
67.34
141.43
4
A
ALA
12
-151.54
-27.00
4
A
SER
57
-135.75
-85.97
4
A
ARG
79
50.54
-84.45
4
A
SER
95
176.53
-129.83
4
A
PRO
107
-67.49
-147.99
4
A
ASP
109
54.66
144.73
4
A
TYR
110
-80.76
43.60
4
A
TRP
112
-160.57
48.36
4
A
ASP
129
-169.35
-138.55
4
A
TYR
133
-69.43
-178.72
4
A
GLU
135
-175.32
-50.84
4
A
TYR
137
-67.61
-161.42
4
A
LEU
140
-89.60
43.97
4
A
SER
141
-177.42
41.88
4
A
ASN
147
-49.47
90.95
4
A
PHE
163
-170.76
-142.22
4
A
SER
166
-101.55
-119.57
4
A
SER
167
71.55
-47.51
5
A
ALA
2
70.81
-56.27
5
A
VAL
4
71.52
-53.54
5
A
ALA
7
62.98
118.56
5
A
ALA
12
-159.67
-36.97
5
A
VAL
29
-89.69
-159.57
5
A
LYS
30
-79.56
-146.28
5
A
SER
41
-130.54
-30.86
5
A
SER
54
-131.21
-82.25
5
A
HIS
63
-92.64
47.10
5
A
LYS
77
-120.02
-155.77
5
A
MET
94
-85.95
-86.11
5
A
SER
95
-154.20
-42.77
5
A
ASP
96
-89.19
31.31
5
A
TYR
108
-98.90
37.45
5
A
ASN
111
-168.94
-123.53
5
A
TRP
112
-105.15
42.77
5
A
LYS
125
71.41
-39.10
5
A
ASP
129
-137.27
-151.56
5
A
GLU
134
-100.52
-139.46
5
A
GLU
135
59.40
-107.84
5
A
TYR
137
-73.52
48.96
5
A
SER
141
-153.85
65.26
5
A
ASN
147
-51.24
93.92
5
A
SER
166
-105.42
-125.16
5
A
SER
167
70.75
-48.11
6
A
ALA
2
69.66
143.30
6
A
VAL
4
-82.68
46.18
6
A
GLU
40
-141.87
39.73
6
A
SER
54
-101.77
-99.79
6
A
SER
57
-131.06
-62.64
6
A
ASP
58
-174.76
37.81
6
A
ILE
59
53.50
-52.59
6
A
PRO
81
-75.39
41.90
6
A
SER
95
-177.27
-55.10
6
A
ASP
96
-89.41
38.95
6
A
TYR
108
-102.91
41.73
6
A
ASP
109
-128.27
-134.40
6
A
ASN
111
-71.75
43.31
6
A
ARG
126
-131.86
-35.97
6
A
ASP
129
-150.68
-124.17
6
A
TYR
138
-91.71
46.60
6
A
ASN
139
-133.52
-44.40
6
A
SER
141
-168.13
56.75
6
A
ASN
147
-56.63
-9.20
6
A
ARG
152
179.78
148.81
6
A
SER
166
-97.45
-112.02
6
A
SER
167
64.59
-54.32
6
A
GLU
173
-116.75
63.75
7
A
ALA
2
71.05
-58.79
7
A
ALA
7
72.24
134.65
7
A
ALA
12
-160.27
-28.98
7
A
ASN
28
-66.95
90.54
7
A
LYS
32
-176.64
142.49
7
A
SER
41
-141.88
-31.62
7
A
ASN
49
-176.28
149.71
7
A
SER
54
-80.85
-86.34
7
A
SER
57
-167.90
-51.16
7
A
ARG
79
-146.90
-47.50
7
A
ALA
83
-80.47
-152.50
7
A
THR
84
52.79
115.89
7
A
SER
95
-164.55
-70.74
7
A
ASP
96
-89.33
48.18
7
A
PRO
107
-77.30
-169.92
7
A
LYS
125
-137.12
-47.68
7
A
ARG
126
61.52
101.68
7
A
ARG
127
70.56
125.11
7
A
TYR
133
-107.49
43.20
7
A
GLU
135
-146.54
42.77
7
A
TYR
137
-173.36
-49.58
7
A
TYR
138
-161.73
43.85
7
A
SER
141
-167.82
68.35
7
A
ASN
147
-28.86
94.20
7
A
TRP
149
-174.48
143.84
7
A
TYR
156
-91.61
47.83
7
A
PHE
163
-173.24
-141.94
7
A
SER
166
-99.80
-127.93
7
A
GLU
173
-116.24
64.17
7
A
THR
177
-145.85
-154.91
8
A
ASP
3
68.86
125.93
8
A
ALA
12
-156.65
-30.37
8
A
GLU
40
-141.12
43.67
8
A
SER
54
-142.55
-63.76
8
A
ASP
58
-174.84
144.20
8
A
HIS
63
-94.38
38.90
8
A
GLN
76
-120.91
-139.69
8
A
ARG
79
66.34
148.29
8
A
ALA
86
-165.55
116.06
8
A
SER
95
-171.31
-51.69
8
A
ASP
109
54.67
-44.54
8
A
TYR
122
-125.75
-164.02
8
A
ARG
126
70.86
137.98
8
A
ASP
129
-158.19
-154.08
8
A
GLU
135
-90.09
-139.04
8
A
SER
141
-158.24
61.95
8
A
ASN
147
-39.88
93.65
8
A
SER
166
-98.69
-125.41
8
A
GLU
173
-112.88
62.35
9
A
ASP
3
66.93
-44.89
9
A
ALA
5
64.50
141.72
9
A
ALA
7
67.12
117.04
9
A
ASP
10
-79.10
29.94
9
A
LEU
26
-82.29
48.05
9
A
ASN
28
-164.23
-44.25
9
A
ASP
58
-175.27
38.58
9
A
ILE
59
53.19
-53.30
9
A
ASN
74
-161.64
115.66
9
A
SER
95
-156.30
-69.81
9
A
TRP
112
-69.84
56.36
9
A
LYS
125
-82.94
-125.39
9
A
ARG
126
-149.58
-49.71
9
A
ASP
129
176.05
-147.60
9
A
GLU
135
74.31
-51.09
9
A
TYR
137
-77.03
37.10
9
A
TYR
138
-146.88
32.95
9
A
ASN
139
-143.28
-43.48
9
A
SER
141
-173.95
70.51
9
A
ASP
146
-171.48
126.02
9
A
ASN
147
-66.14
3.57
9
A
TRP
149
-170.97
131.58
9
A
LEU
154
-158.94
-28.75
9
A
PHE
163
-168.12
-166.99
9
A
SER
166
-82.78
-133.24
9
A
SER
167
61.94
-149.04
10
A
ASP
3
69.68
-46.55
10
A
VAL
4
50.98
-152.85
10
A
ALA
5
67.94
-64.35
10
A
ALA
12
-165.83
-24.18
10
A
ASN
28
-79.23
47.61
10
A
LYS
30
-63.99
-71.76
10
A
LEU
48
-100.43
-61.90
10
A
ASN
49
-176.37
146.53
10
A
SER
54
-91.02
-97.95
10
A
SER
57
-170.32
-146.00
10
A
HIS
63
-179.99
-53.66
10
A
ASP
78
-163.62
-136.86
10
A
THR
84
58.37
165.58
10
A
ALA
86
-172.26
128.77
10
A
SER
95
-169.26
-51.81
10
A
TYR
108
-95.21
47.98
10
A
ASP
109
66.40
104.89
10
A
TRP
112
-145.32
50.04
10
A
ASN
118
-164.50
116.00
10
A
LYS
123
-79.82
44.60
10
A
LYS
125
72.28
-40.95
10
A
ASP
129
-161.05
-160.36
10
A
GLU
135
69.87
-68.45
10
A
TYR
138
-167.91
-45.19
10
A
SER
141
-158.41
64.78
10
A
ASN
147
-58.14
89.33
10
A
PHE
163
-172.09
-162.33
10
A
SER
166
-80.95
-127.11
10
A
SER
167
63.10
-151.92
11
A
VAL
4
69.73
-57.77
11
A
ALA
5
68.31
140.59
11
A
ALA
7
-83.40
41.85
11
A
ALA
12
-156.84
-29.11
11
A
LEU
26
-83.59
47.64
11
A
SER
41
-145.83
-10.12
11
A
SER
54
-129.49
-80.26
11
A
ASP
58
-165.34
37.78
11
A
ILE
59
58.27
-47.62
11
A
PRO
66
-91.13
-126.06
11
A
LYS
77
-83.16
-141.97
11
A
ASP
78
71.54
142.09
11
A
ARG
79
-171.42
-42.14
11
A
MET
94
-85.61
-92.16
11
A
SER
95
-150.71
-40.95
11
A
ASP
96
-89.62
32.95
11
A
TYR
108
-86.47
43.27
11
A
TYR
110
-117.93
58.63
11
A
ASN
111
-149.75
-123.84
11
A
TRP
112
-75.62
48.55
11
A
ASP
129
-126.02
-160.39
11
A
GLU
134
-88.30
43.38
11
A
GLU
135
-94.31
-134.18
11
A
ASN
139
-90.42
48.27
11
A
SER
141
-167.63
66.74
11
A
ASN
147
-37.34
99.04
11
A
TRP
149
-173.09
139.44
11
A
SER
166
-105.99
-130.29
11
A
SER
167
70.61
-42.60
12
A
ALA
2
67.87
-62.96
12
A
VAL
4
73.52
129.71
12
A
ALA
12
-173.77
43.76
12
A
SER
13
-144.97
-39.81
12
A
LEU
26
-81.52
37.39
12
A
SER
41
-166.44
-24.16
12
A
SER
54
-134.96
-57.05
12
A
SER
57
-148.84
-76.84
12
A
ASP
58
-166.25
40.57
12
A
ILE
59
49.73
-65.47
12
A
PRO
62
-41.71
157.58
12
A
HIS
63
-73.80
-110.89
12
A
SER
95
-150.90
-69.88
12
A
ASP
109
-147.94
-136.94
12
A
ASN
111
-70.76
40.51
12
A
LYS
125
-75.28
44.44
12
A
TYR
137
-81.90
-98.96
12
A
TYR
138
-172.19
120.91
12
A
ASN
139
-147.06
-34.63
12
A
SER
141
-166.10
64.44
12
A
ASN
147
-49.25
97.31
12
A
TRP
149
-179.14
135.35
12
A
SER
166
-104.25
-135.23
12
A
GLU
173
-107.12
51.63
13
A
ALA
12
-150.69
-46.82
13
A
ASN
28
-66.57
98.80
13
A
SER
54
-151.92
-63.27
13
A
SER
57
-164.17
-80.30
13
A
HIS
63
-66.53
-143.87
13
A
ARG
79
-155.47
-50.32
13
A
THR
84
-152.41
-47.50
13
A
SER
95
-155.70
-55.06
13
A
TYR
108
-90.47
-139.72
13
A
ASP
109
-97.37
43.41
13
A
LYS
123
-95.99
48.76
13
A
LYS
125
71.99
-46.24
13
A
ASP
129
-146.57
-155.79
13
A
GLU
134
-85.73
48.43
13
A
GLU
135
-81.47
-122.62
13
A
TYR
137
-176.53
-50.28
13
A
ASN
139
-133.24
-49.75
13
A
SER
141
-160.72
65.62
13
A
ASN
147
-44.61
95.52
13
A
TRP
149
-173.59
121.09
13
A
PHE
163
-174.52
149.87
13
A
SER
166
-96.98
-131.39
13
A
GLU
173
-108.46
58.16
14
A
ALA
2
-84.94
45.24
14
A
VAL
8
-144.74
58.78
14
A
ALA
12
-157.33
-31.04
14
A
LEU
26
-82.32
38.32
14
A
ASN
49
-172.43
147.82
14
A
SER
54
-98.00
-100.60
14
A
THR
56
-171.29
149.68
14
A
ASP
58
-171.51
148.02
14
A
THR
84
-130.48
-47.86
14
A
SER
95
-163.18
-74.42
14
A
ASP
129
-162.78
-161.09
14
A
GLU
134
-94.70
32.68
14
A
LEU
136
-89.68
-96.45
14
A
TYR
137
-162.34
-58.94
14
A
TYR
138
-89.02
44.11
14
A
ASN
147
-0.21
88.14
14
A
PHE
163
177.30
167.28
14
A
ALA
170
-170.76
-129.76
14
A
LEU
172
-161.84
112.20
14
A
THR
177
-144.06
-155.65
15
A
ALA
2
67.86
128.75
15
A
VAL
4
-130.48
-55.92
15
A
ALA
5
68.66
144.40
15
A
ILE
9
-104.15
-150.59
15
A
ALA
12
-150.52
-29.62
15
A
LEU
26
-59.69
-70.62
15
A
SER
41
-142.34
-22.78
15
A
THR
46
-118.50
-110.52
15
A
ASN
49
-173.23
144.72
15
A
SER
54
-102.94
-111.78
15
A
HIS
63
-108.07
57.51
15
A
LYS
64
-164.10
117.50
15
A
PRO
66
-81.72
-135.04
15
A
ASP
78
-167.23
107.35
15
A
ARG
79
-156.77
-63.51
15
A
PRO
81
-67.68
-136.64
15
A
SER
95
-172.71
-93.14
15
A
ASP
109
69.74
-49.77
15
A
LYS
125
-172.15
-39.68
15
A
ASP
129
-160.56
-157.64
15
A
TYR
138
-85.69
39.04
15
A
SER
141
-175.13
68.61
15
A
ARG
144
73.70
-6.14
15
A
ASP
146
-171.59
137.51
15
A
ASN
147
-45.66
94.96
15
A
SER
166
-81.82
-122.14
15
A
SER
167
65.74
-151.48
16
A
ALA
2
-94.86
47.54
16
A
VAL
4
72.01
-47.13
16
A
ALA
5
-151.00
-41.26
16
A
ALA
12
-160.15
-30.93
16
A
GLU
40
-117.69
67.58
16
A
SER
54
-104.43
-90.15
16
A
THR
56
-170.33
147.22
16
A
HIS
63
-77.05
48.36
16
A
LYS
64
-171.36
123.55
16
A
PRO
66
-82.81
-144.67
16
A
ARG
79
-142.46
-62.39
16
A
ALA
83
-77.49
39.30
16
A
ALA
86
-164.22
114.26
16
A
SER
95
-171.29
-72.11
16
A
ASP
109
71.88
148.16
16
A
ASN
111
-162.47
-142.43
16
A
TRP
112
-93.55
41.19
16
A
LYS
123
-92.89
46.96
16
A
LYS
125
68.87
-47.04
16
A
TYR
133
-77.46
-127.46
16
A
GLU
135
-172.35
-106.02
16
A
TYR
137
-76.67
44.50
16
A
TYR
138
-111.72
-110.89
16
A
LEU
140
-152.24
-144.17
16
A
ASN
147
-49.03
96.82
16
A
TRP
149
-171.50
125.68
16
A
SER
166
-81.74
-124.23
16
A
SER
167
67.74
-148.33
16
A
GLU
173
-113.10
76.92
17
A
ASP
3
65.19
135.41
17
A
ALA
5
-151.76
36.70
17
A
ALA
12
-131.92
-46.66
17
A
SER
13
-83.27
44.54
17
A
ASN
28
-100.37
-93.48
17
A
LEU
48
-121.93
-50.31
17
A
SER
54
-121.23
-76.76
17
A
SER
57
-109.59
-67.50
17
A
ASP
58
-172.47
37.11
17
A
ILE
59
65.05
-57.34
17
A
PRO
62
-48.28
-77.96
17
A
HIS
63
-175.07
-58.93
17
A
ARG
79
66.60
137.55
17
A
SER
95
-168.89
-48.33
17
A
ASP
96
-89.41
32.34
17
A
ASP
109
59.48
-38.82
17
A
LYS
125
48.27
-153.80
17
A
ARG
126
69.89
137.92
17
A
MET
132
-90.96
-62.26
17
A
TYR
133
-153.00
36.36
17
A
GLU
134
-102.55
60.56
17
A
GLU
135
-77.38
-144.22
17
A
TYR
137
-162.52
-46.50
17
A
ASN
139
-149.52
-49.92
17
A
ARG
144
73.00
-10.60
17
A
ASN
147
-54.34
91.10
17
A
ARG
152
-175.69
140.32
17
A
LEU
154
-154.67
-26.39
17
A
PHE
163
179.56
177.17
17
A
SER
166
-91.76
-124.60
17
A
GLU
173
-114.42
57.42
17
A
THR
177
-141.66
-159.51
18
A
ALA
2
67.24
119.86
18
A
VAL
4
-79.85
45.62
18
A
ALA
7
-158.56
46.48
18
A
ALA
12
-157.58
-37.26
18
A
LEU
26
-95.86
32.30
18
A
SER
41
-151.94
-31.10
18
A
THR
46
-108.26
-104.99
18
A
ALA
47
-172.84
118.05
18
A
SER
54
-125.89
-63.04
18
A
SER
57
-159.03
-159.85
18
A
ASP
58
-83.81
44.81
18
A
ILE
59
55.35
-54.11
18
A
PRO
66
-82.05
-156.91
18
A
ARG
79
-168.45
-39.99
18
A
THR
84
-157.99
-54.44
18
A
SER
95
-171.90
-74.48
18
A
ASP
96
-88.90
46.85
18
A
ASP
109
-145.07
-141.79
18
A
ARG
127
74.21
128.67
18
A
ASP
129
-154.71
-146.92
18
A
TYR
133
-143.26
25.99
18
A
GLU
134
-99.91
54.94
18
A
GLU
135
-144.94
-56.55
18
A
TYR
138
-86.06
45.94
18
A
ASN
139
-125.63
-56.75
18
A
SER
141
-152.91
68.54
18
A
ASN
147
-45.89
96.18
18
A
TYR
156
-83.73
42.15
18
A
SER
166
-171.82
121.72
18
A
GLU
173
-118.55
77.41
19
A
ALA
2
-163.80
-50.69
19
A
ALA
7
68.79
125.24
19
A
ALA
12
-143.58
-27.26
19
A
LEU
26
-83.24
46.70
19
A
LYS
30
-83.45
40.31
19
A
ARG
31
-169.35
85.14
19
A
SER
41
-142.40
-80.80
19
A
THR
46
-122.13
-120.18
19
A
ASN
49
-177.97
148.02
19
A
SER
54
-145.85
-78.45
19
A
SER
57
-124.09
-53.55
19
A
HIS
63
-93.60
44.08
19
A
LYS
64
-161.64
113.67
19
A
PRO
66
-78.50
-119.80
19
A
GLN
76
-116.01
-138.78
19
A
ARG
79
72.04
131.63
19
A
SER
95
-169.53
-62.27
19
A
ASP
109
70.30
-71.49
19
A
ARG
127
71.47
125.84
19
A
ASP
129
-163.91
-154.19
19
A
GLU
135
-159.78
-70.93
19
A
TYR
138
-164.42
-25.98
19
A
SER
141
-175.36
67.87
19
A
ASN
147
-52.28
94.90
19
A
TRP
149
-171.65
132.52
19
A
PHE
163
-175.86
146.38
19
A
SER
166
-88.97
-123.85
19
A
SER
167
71.71
48.41
20
A
ALA
5
-158.02
-44.82
20
A
ALA
7
-142.07
50.00
20
A
ALA
12
-168.35
-33.61
20
A
ASN
28
-87.41
39.34
20
A
THR
46
-89.21
-130.86
20
A
SER
54
-143.84
-79.00
20
A
SER
57
-157.33
-52.64
20
A
PRO
62
-59.19
-106.21
20
A
HIS
63
-154.56
-48.36
20
A
PRO
66
-75.71
-156.93
20
A
ARG
79
-167.87
-28.33
20
A
PRO
81
-74.86
-135.79
20
A
MET
94
-92.33
-60.83
20
A
SER
95
-171.07
-61.73
20
A
ASP
96
-89.05
43.79
20
A
TYR
108
-82.98
40.26
20
A
ASN
111
-141.26
-129.51
20
A
TYR
133
-136.16
-37.13
20
A
GLU
135
73.48
-46.51
20
A
ASN
147
-47.14
93.36
20
A
SER
166
0.72
75.09
20
A
SER
167
-7.84
-51.52
20
A
ALA
170
-163.25
-140.38
20
A
GLU
173
-94.31
57.24
Solution structure of the eukaryotic pore-forming cytolysin equinatoxin II
1
N
N
A
SER
15
A
SER
15
HELX_P
A
ALA
25
A
ALA
25
1
1
11
A
ASP
129
A
ASP
129
HELX_P
A
GLU
134
A
GLU
134
1
2
6
MEMBRANE PROTEIN
cytolysin, pore formation, beta sandwich, toxin, sea anemone, MEMBRANE PROTEIN
EQT2_ACTEQ
UNP
1
36
P61914
SADVAGAVIDGASLSFDILKTVLEALGNVKRKIAVGVDNESGKTWTALNTYFRSGTSDIVLPHKVPHGKALLYNGQKDRG
PVATGAVGVLAYLMSDGNTLAVLFSVPYDYNWYSNWWNVRIYKGKRRADQRMYEELYYNLSPFRGDNGWHTRNLGYGLKS
RGFMNSSGHAILEIHVSKA
36
214
1KD6
1
179
P61914
A
1
1
179
1
SER
SEE REMARK 999
THR
177
1KD6
A
P61914
UNP
212
177
5
5
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
LYS
69
A
LYS
69
A
GLY
75
A
GLY
75
A
ILE
33
A
ILE
33
A
ASN
39
A
ASN
39
A
ALA
170
A
ALA
170
A
THR
177
A
THR
177
A
LYS
159
A
LYS
159
A
ASN
165
A
ASN
165
A
HIS
150
A
HIS
150
A
ASN
153
A
ASN
153
A
THR
46
A
THR
46
A
PHE
52
A
PHE
52
A
GLY
88
A
GLY
88
A
LEU
93
A
LEU
93
A
ASN
98
A
ASN
98
A
SER
105
A
SER
105
A
TRP
116
A
TRP
116
A
LYS
123
A
LYS
123
A
PHE
143
A
PHE
143
A
ARG
144
A
ARG
144